Bespak, one of the two contract manufacturers of Pfizer's inhaled
insulin Exubera, has announced it will cut a "significant" number
of jobs as sales of the once-touted blockbuster are falling short
Just over a week after Roche was forced to initiate a Europe-wide
recall of HIV drug Viracept (nelfinavir), in-PharmaTechnologist.com
considers the contamination case and the pharmaceutical processes
blamed for the incident.
The European Commission has released figures showing that there has
been a dramatic and concerning increase in pharmaceutical
counterfeiting, with seizures in Europe hitting an all time high of
over 2.5m items.
A UK-based technology company is part of a trio leading the way in
innovative supply chain solutions by combining real-time
temperature monitoring with a radio frequency identification (RFID)
tag for the pharmaceutical industry.
Reliance on contract packaging staff is increasing and it is
currently a 'contractor's market.' However, the biggest challenge
in a packaging laboratory - stability - will only be overcome as
An online database detailing information on all manufacturing and
importation certificates and authorisations issued within the
European medicines network has been launched by the European
Medicines Agency (EMEA).
SAFC Pharma, the contract manufacturing arm of Sigma-Aldrich, has
announced it has completed the construction of two protein active
pharmaceutical ingredient (API) facilities at its US manufacturing
US diabetics will soon have a new alternative to the predominant
needle and syringe method of administering insulin, now that the
Food and Drug Administration (FDA) has granted marketing approval
to Sanofi-Aventis' Lantus SoloStar.
West Pharmaceutical Services reported a 40 per cent increase in
operating profit for the first quarter of 2007, despite profits
diving 43 per cent in the Tech Group business that makes the
delivery device for Pfizer's inhaled...
Indian contract research and manufacturing services (CRAMS) firm
Jubilant Organosys has announced the purchase of US-based company
Hollister-Stier Laboratories for $122.5m (€90m) in what
represents one of the largest overseas acquisitions...
Swiss contract manufacturer Lonza has announced it will invest
around $300m (€220m) in the expansion of its US biomanufacturing
plant, just two weeks after kicking off the construction of a
similar facility in Singapore.
Hospira's US injectables contract manufacturing unit reported a
sales jump of 32 per cent to $43.4m (€33m), however, this stellar
performance is not indicative of the strength of the unit or the
performance expected to follow...
Using contractors to fulfil packaging needs can significantly
reduce the time new products take to hit the market, claimed Gareth
Lewis of Cardinal Health, speaking at SMi's Pharmaceutical
Packaging and Labelling conference in...
The number of product recalls in the UK jumped by 8 per cent in the
last year, with the problem compounded by the trend towards
outsourcing to developing countries such as those in Asia, says law
firm Reynolds Porter Chamberlain (RPC).